Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

The FDA approves lamivudine for the treatment of chronic HBV

Dec. 10, 1998

In vitro and clinical study results support development of nitazoxanide for H. pylori infection

Dec. 10, 1998

Eisai begins product launch of proton pump inhibitor in Germany

Dec. 8, 1998

Six-month treatment with ciprofloxacin improves response rate in ulcerative colitis

Dec. 4, 1998

Agents for ulcers synthesized and evaluated at Shiseido

Dec. 3, 1998

AxyS initiates phase I studies of APC-2059 for treatment of acute inflammatory bowel disease

Dec. 3, 1998

Lead SelCID compound poised to enter phase II clinical trials for Crohn's disease

Dec. 2, 1998

Health Canada approves lamivudine for treatment of chronic HBV

Dec. 2, 1998

AMBI seeks partners to develop oral nisin for H. pylori eradication

Dec. 2, 1998

Multiple clinical studies support efficacy and safety of HSR-237 in patients with IBS

Nov. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...